MENU

CSBR Stock Tickeron detected bullish Stock Pattern: Triangle Symmetrical Top CSBR on December 09, 2024, netting in a 26.68% gain over 5 days

A.I.dvisor
at Tickeron.com
Loading...
+26.68% Gain from a Successful pattern Triangle Symmetrical Top
CSBR - Champions Oncology
Tickeron
Ticker: CSBR
Company: Champions Oncology
Gain: +26.68%
Confirmed: 12/09/24
Succeeded: 12/11/24
Total length: 5 days
On December 06, 2024, A.I.dvisor detected a Triangle Symmetrical Top Pattern (Bullish) for Champions Oncology (CSBR, $4.61). On December 09, 2024, A.I.dvisor confirmed the Bullish pattern, setting a target price of $5.99. 2 days later, on December 11, 2024, CSBR reached the target price resulting in a +2 for traders who took a long position in the stock.

Aroon Indicator for CSBR shows an upward move is likely

CSBR's Aroon Indicator triggered a bullish signal on December 10, 2024. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 130 similar instances where the Aroon Indicator showed a similar pattern. In of the 130 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 05, 2024. You may want to consider a long position or call options on CSBR as a result. In of 113 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CSBR just turned positive on December 06, 2024. Looking at past instances where CSBR's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

CSBR moved above its 50-day moving average on December 06, 2024 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CSBR crossed bullishly above the 50-day moving average on December 09, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CSBR advanced for three days, in of 257 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

CSBR broke above its upper Bollinger Band on December 13, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CSBR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CSBR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CSBR's P/B Ratio (140.845) is slightly higher than the industry average of (14.664). P/E Ratio (0.000) is within average values for comparable stocks, (87.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). CSBR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (1.808) is also within normal values, averaging (260.687).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
CSBR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of advanced technology solutions and services for oncology drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
One University Plaza
Phone
+1 201 808-8400
Employees
230
Web
https://www.championsoncology.com